Frequently Asked Questions
Q1: Are your RPM devices approved for use in Canada?
A: Absolutely. We only deploy Class II and Class III medical devices that have been cleared by Health Canada’s Medical Devices Bureau. Each device in our catalogue—blood pressure cuffs, glucometers, pulse oximeters, weight scales, and ECG patches—carries an active Medical Device Licence (MDL). In addition, Cabot performs a secondary verification with the device manufacturer to confirm batch-level certifications and recalls. This dual-layer validation helps you maintain full compliance and simplifies documentation during audits or accreditation reviews.
Q2: Can the platform integrate with my existing EMR?
A: Yes. Our integration engine supports HL7 v2, FHIR R4, and proprietary APIs, allowing seamless connectivity with popular Canadian EMRs such as TELUS PS Suite, OSCAR, Accuro, Med Access, and Epic. We start by conducting a technical discovery session to map data fields, identify interface points, and create a security profile. Next, we build and test the interface in a sandbox environment, followed by a monitored production rollout. Post-deployment, our Integration Support Desk manages version upgrades and monitors message queues to ensure uninterrupted data flow.
Q3: How is patient data protected?
A: Data security is engineered into every layer of our solution. All data in transit is protected with TLS 1.3 while data at rest is encrypted with AES-256. We employ role-based access controls (RBAC) and multi-factor authentication (MFA) to limit user privileges to the minimum required. Our cloud infrastructure is hosted on ISO 27001-certified data centres located within Canada to satisfy data residency requirements. Quarterly penetration tests, daily vulnerability scans, and real-time SIEM monitoring further protect the environment. Detailed audit logs are retained for a minimum of seven years to comply with PHIPA and PIPEDA mandates.
Q4: What languages are supported for patients?
A: Out of the box, our patient-facing mobile and web apps are available in English and French, covering the majority of Canada’s population. We have a modular internationalization (i18n) framework that allows rapid addition of other languages such as Punjabi, Mandarin, Arabic, or Inuktitut. All translations are performed by medical-grade linguists and reviewed by bilingual clinicians to ensure terminology accuracy. The same framework extends to SMS alerts, email notifications, onboarding videos, and printed instructions, creating a consistent multilingual experience across every touchpoint.
Q5: How quickly can we launch an RPM program?
A: A pilot program serving up to 50 patients can typically go live within 6–8 weeks. Week 1 entails stakeholder alignment and requirements gathering. Weeks 2–4 cover device procurement, platform configuration, and initial EMR integration. By Week 5, we conduct user acceptance testing (UAT) and clinical workflow dry-runs. Week 6 is reserved for clinician training, patient onboarding, and final go-live. For larger rollouts exceeding 1,000 patients or involving multi-site health systems, we recommend a phased approach that scales capacity in two-week sprints without disrupting existing clinical operations.
Q6: Do you offer clinical monitoring services?
A: Yes. Cabot partners with a network of licensed Canadian Registered Nurses (RNs) and Nurse Practitioners (NPs) who provide 24/7 monitoring from our PHIPA-compliant telehealth centre. Our clinical team reviews incoming vitals, applies evidence-based triage protocols, and escalates abnormal readings according to your organization’s standing orders. For providers who prefer to keep monitoring in-house, we deliver a turnkey toolkit that includes triage algorithms, escalation matrices, and training modules so your staff can assume full control without starting from scratch.
